Pglyrp1-Cre Marks Distinct Epithelial and Immune Lineages Across Mucosal Sites

preprint OA: closed CC-BY-NC-ND-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Mucosa-associated lymphoid tissue (MALT) initiates immune responses at mucosal entry sites. Within MALT, microfold (M) cells sample luminal antigens and deliver them to underlying immune cells. Despite their functional importance, few tools enable selective manipulation of M cells in vivo . Here we report the generation and characterization of a peptidoglycan recognition protein 1 ( Pglyrp1 )-Cre knock-in mouse designed to allow conditional genetic access to M cells. Using Rosa26-tdTomato reporter mice, we found strong Pglyrp1 promoter activity in gut epithelial cells, including goblet and M cells, whereas activity in nasal-associated lymphoid tissue (NALT) was more heterogeneous and skewed towards immune cells, particularly neutrophils. To functionally interrogate Pglyrp1 -expressing cells, we performed Cre-mediated ablation using three DTA-based models. The Rosa26 GFP-DTA line caused marked perinatal lethality in double-positive pups, suggesting essential roles for Pglyrp1-positive cells early in life. In contrast, Rosa26 DTA and Rosa26 iDTR crosses produced minimal depletion of mucosal populations, including M cells, even at the highest non-lethal diphtheria toxin dose. These findings demonstrate tissue-specific Pglyrp1 promoter activity and highlight challenges in achieving M cell-specific targeting. Although not M cell-restricted, the Pglyrp1-Cre mouse provides a useful tool for manipulating Pglyrp1-expressing lineages and probing their roles in mucosal homeostasis and immunity.
Full text 56,404 characters · extracted from oa-pdf · 7 sections · click to expand

Abstract

14 Muc os a-a ss oc iat ed l y mph oid tis su e ( MAL T) init iat es im mune r e spo nses a t 15 muc os al ent ry si t es . Wi th in MAL T , m ic r ofold (M ) c ells sa mple lu min al antig ens and 16 d e l i ver th em to u n de rlyi n g i mm un e c e l ls . D e spit e th ei r funct i onal i mpo rtan ce , f ew 17 t ool s enabl e sele ct i v e manipul at ion of M c ells in vivo . H er e w e r ep or t the gen er ati on 18 and ch ar ac t er iza ti on of a p eptid o gl y c an r ec ogni ti on pr ot e in 1 ( Pglyrp1 )-Cr e kno ck-in 19 mou se de sign ed t o all ow c ondi ti ona l gene ti c a cc ess t o M c ells. Using R o sa26-t d T o mat o 20 re p or ter mi ce , we fo und s tr ong Pglyrp1 p r o mo t e r ac tivi ty i n g u t epit heli al c ells, 21 including go ble t and M c ells, w he r ea s a c ti vi ty in na sal-a ss oc iat ed l y mpho id tis sue 22 (N AL T ) w a s mo r e het er ogen eou s and sk ew ed t ow ar d s i mm une cell s, pa rt ic ula rl y 23 neutr oph ils. T o func ti onall y int e rr o g at e Pglyrp1 -e xpr ess ing c ells, w e p erfo rm ed C r e-24 med iat ed abl ati on us ing thr ee D T A- bas ed m odel s. Th e R os a26 GFP- DT A line c aus ed 25 ma rk ed pe rina tal l et hali ty in d ou ble-po si ti v e pups , s ugges ting es se ntial r ol es for 26 P gl yrp1-p os it i v e cell s e ar l y in l ife . In c on tras t , R o sa 2 6 DT A and Rosa 2 6 iD TR cr osse s 27 pr odu ced m ini mal depl eti on of m uco sal popul at ions , includ ing M c e lls, e v en a t th e 28 high es t n on-leth al d ipht her ia toxi n d o se . T he se fi ndings de mons tr at e ti ssu e-spe c ific 29 Pglyrp1 p r o mo ter ac tivi ty and h ighl igh t ch allenge s in ach ie v ing M cell-sp ec ifi c 30 ta rge ting. Alt hou gh n ot M c ell-r e st ri ct ed, th e P gl yrp1- Cr e m ous e pr o v id es a useful t o ol 31 for man ipula ting P gl yrp1-e xp r es si ng line age s and p r o bing the ir r ol es in mu c osal 32 hom eo st as is and i mm unity . 33 34 K e yw or d s: P gl y rp1- Cre; M c e l l s; M uc os a l i m muni ty 35 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint

Introduction

36 Muc os a-a ss oc iat ed l ymph oid t iss u e ( M AL T ) p lays a c e nt r a l r o l e i n i m mune 37 defense at m aj or s it e s of pa thog e n ent ry , in cluding t he g as tr oint es t inal (G I) t r ac t , 38 r esp ir at o ry sy st em , skin, and g e nit ou rina ry trac t [1]. M AL T con si st of o rg an ized 39 l ymph oid foll icl es c o vere d b y s pe ci a l i ze d e p i thel ial l a y er s, wi th P e y er’ s pat che s 40 ser ving as th e be st-c h arac terized e x ampl e [2]. F r om s tudi es of P eyer ’ s p a t c he s , 41 mi cr ofold ( M ) c ells w er e id entified as r ar e ep ith eli al c ells t hat sa mple l uminal ant igens 42 and del i v e r t he m t o s ub epi thel ial i mmun e cells th r o ugh t r ans cyt os is [3]. Th is proce s s 43 is e xpl oit ed b y pa th ogens su ch as Salmonella , Y ersinia , Shigella , and Mycobacterium 44 tuberculosis t o ent er the h ost [4-7]. M c ells the r ef ore p l a y c r it ic a l r o le s i n mi crob ia l 45 path ogen esi s and mu c osal i mmun e su rvei l l a n ce [8]. 46 Despit e the ir i mpo rt ance , t ool s th at sel ec ti v el y t a rge t M cells in vivo r em ain 47 limit ed. Appr oa che s h a v e in clude d disrup ting RA NK-R A NKL s ignaling t o m odulat e M 48 cell ab undanc e [9], o r u sing mu c os al ad ju v an ts su ch as c hol er a t o xin [ 10]. Gen et ic all y 49 engine er e d m odels su ch a s Spib - or Sox8 -defi ci ent m i ce [11, 12] and Villin -C r e-dr i v en 50 cond iti onal kno ck o uts t ar get ing T nfrsf11a ( RA NK ) , Gp2, or Atoh8 [13-16] ha v e 51 a d va nc e d t he fi e l d, yet ma ny l ac k ce l l -typ e spe cific ity and af fec t br oad er ep ith eli al 52 co mpa rt ment s. 53 P ept ido gl y c an r ec ogni ti on pr ot e in 1 (PGL Y RP1 ), al so kn o wn as P GR P , PGRP-S , 54 T A G7, or TNF AF3L, is an innat e i mmun e r ec ept o r e xpr ess ed in se v er al c ell typ es . 55 PGL YRP1 h as b een det ec t ed in M c ells of P e y e r’s pat ch es, w h er e i t col oc alize s wi th M 56 cell m ark er s su ch as Ulex europaeus ag glut inin 1 (UE A-1) and GP2 [ 10, 17], and in 57 RA NKL-indu ced M cell s d er i v ed fr o m int es tin al o rg ano ids [18]. P GL YRP1 i s als o 58 e xpr es sed in neu tr ophil s, epit hel i al c ells, and s tr om al popul at ions [19-21]. The se 59 obs er v at ions sugg est ed Pglyrp1 a s a p ot en ti al pr om ot e r fo r M c ell-spe cif i c Cr e 60 e xpr es si on. 61 H e r e we de sc ri be t he g e n erat io n a nd c h arac te riza ti on of a Pglyrp1 -Cr e knock-in 62 mou se . Alth ou gh ini ti all y int ended fo r M c ell ta rg et ing, Pglyrp1 -Cr e d r o v e 63 r e co mb inat ion in a br oa der s et of epi th elial and i mmun e p opula ti o ns in a ti ssu e-64 spec ifi c manner . Us ing flu or es cen t r epo rt e r and d iphth er ia toxi n-bas ed abl at ion 65 mod els, w e m apped Pglyrp1 -e xpr ess ing line age s and unc o v er ed t hei r func ti onal 66 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint signifi c ance . Whil e n ot M cell-sp ec ific , thi s mod el pr o v ide s a v er sat ile t o ol f o r 67 manipul at ing Pglyrp1 -pos it i v e c ell s in vivo and for pr ob ing the ir c ontr ibu ti ons t o 68 muc os al bar ri er int eg ri ty and innat e i mm unity . 69 70

Results

71 Gener ation of a Pglyrp1 -Cr e mouse model and founder scr eening 72 T o gen et ic all y ta rg et Pglyrp1 -e xpr e ssing cell s, w e g ene r at ed a kno ck-i n mou se 73 in w hi ch C r e r ec o mb inas e w as in s ert ed d o wnst r e am of e x on 3 of th e P gl y rp1 lo cus 74 using t he Ea si- CR ISPR me th od [22 ]. Thi s appr o ach pres er v e s endog e nous pr o mot er 75 r egul ati on w hil e m ini mizing di sru ption t o Pglyrp1 gen e funct ion (F igur e 1A ). T he 76 s i n g le - s tra n de d DNA (s s DNA) do n or u se d fo r r e co mb i na t io n i n c l u de d h o mo l ogy ar ms , 77 an int ern al ri bo so me entr y sit e ( IR ES), and th e Cr e c oding s eq uenc e ( Figur e 1B ). T he 78 full r e co mb ined e x on 3 se quen ce and don or t e mplat e s ar e sh o wn i n Supplem ental 79 Figur es 1A and B . 80 F ounder an im als w ere bo r n at ex pec te d M endel ian r a ti os , w er e p hen ot ypic all y 81 norm al, and r e main ed fe rt ile. F o r g enot yping w e us ed pr im er pai rs sp anning th e 5@iLH 82 and 3@iLH junct i ons of th e ins er ti on ( Figur e 1C ) th at g ener at ed d is tinc t PCR pa tt e rns f o r 83 wild-t ype and kn ock- in all ele s. R e str ic ti on enzym e d ige sti on wi th E co RI and Nh eI 84 furth er c onfir med c or r e ct ca ss ett e i nt egr a ti on (Supple ment al F igur es 1 C-1E ). 85 The se anal y se s v e rifi ed suc ce ssful g ener at ion of the Pglyrp1 - Cre k n oc k -i n line . 86 87 Reporter expr ession in newborn Pglyrp1 -Cre mice r ev eals tissue-specific 88 patterns 89 T o e x am ine P glyrp1 - d ri ve n C r e ac tivi t y , w e c r o ss e d Pglyrp1 - C re mi ce w i th 90 B6.Cg-G t( R OS A)26S or tm14(CA G-td T om ato )Hze /J (als o kn own as R o sa26-t d T o mat o) r epo rt e r 91 mi ce [23]. T o e x am ine w h ole- bo d y r ep ort er e xpr es si on dur ing e ar l y de v elop men t , 92 one-d a y-old pups w er e fi x ed, s ec ti oned, and st ain ed f o r RFP and th e M c ell ma rk er 93 GP2 [17]. 94 T h e G I trac t ex hi bi te d st r ong T om a t o e xp r es si on in Pgly r p1 Cr e/wt R osa2 6 tdT om/wt 95 pups, w ith cle ar c olo cal izat ion be t w een T om at o and GP2 (F igur e 2A ; Supplem ent al 96 Figur e 2 A). C ontr ol mi ce l ack ing C r e sh ow ed onl y GP2 s ta ining. A clos er exami n a ti o n 97 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint of the G I tr ac t sh ow ed th at T o mat o -onl y c ont r ols la ck ed o v e rlap bet w een T o mat o and 98 GP2 signal s, w ith onl y GP2-p os it i v e c ells vi si ble ( Fig ure 2A , t o p r o w , open 99 arr ow h ead s) . In c ontr as t , c olo cal iz ati on of T o mat o and GP2 ( ast er isk s ) w a s o bs erve d 100 exc l us i v e ly i n t he pres e nc e o f Cre r e co mb i na s e (Figure 2A , bo t t o m r o w) . Not a bly , 101 To m a t o + GP2 − c ells ( clo sed ar r ow h e ads) w er e m or e abund ant th an T o mat o − GP2 + cell s 102 (op en ar r ow he ads ), indi ca ting P gl y rp1 e xpr ess ion in ep ith eli al li neage s be y ond 103 clas si cal M c ells. 104 In th e N AL T , T o mat o e xpr es si on w a s det ect ed onl y in Cr e-po si ti v e mi ce ( Figur e 105 2B, bo tt o m r ow , clos ed ar r ow h ea ds). GP2 s ta ining w as r a rely ob ser v e d i n e it h er 106 cont r ol mi ce or Pglyrp1 -Cr e m ic e, s ugges ting e ith er v e ry l ow M c ell a b undance at t hi s 107 stag e (F igu r e 2B , Supplem ent al Fi gur e 2B ) o r th at G P2 is n ot a r el i able ma rk er fo r 108 N AL T M cells , con sist ent wi th r e cen t finding s in hum an a ir w a y ti ssu e [2 4]. 109 The se obs er v at ions indi cat e t issu e-spe cific Pglyrp1 p rom o t e r a ctiv it y , wi th 110 r o bus t epi thel ial e xpr ess i on in the GI tr a ct bu t li mit ed or und et e ct abl e e xpr es si on of 111 canon ic al M cell ma rk ers su ch as GP 2 in t he upper a ir w a y mu co sa. 112 113 Quantitati v e anal ysis of P gl yrp1-Cre–dri v en T omato expression in adult mice 114 highlights tissue-specific patterns 115 T o ch ar act er ize P gl yrp1-dr i v en r ep ort er e xpr ess ion at s ingle- cell r es ol uti on, w e 116 perfo rm ed f l ow cyt om et ry on G I t r ac t and N AL T t is sue s fr o m adul t mi ce ( 8-12 w e eks 117 of ag e) c arr ying Cr e, the T o mat o r e port er , or bo th allele s. Th e ant ib od y panel includ ed 118 ma rk e rs fo r ep ith eli al line age s, im mune s ubs et s, and M c el l populat ion s 119 (Supplem ent al F igur e 3 A, o r ang e boxes ). Imm une p opul ati ons w ere i nc l uded b as ed on 120 pr e vi ou s r epo rts i mplic at ing PGL Y RP1 in b oth innat e and adapt i v e i mmun ity , as w ell 121 as its in v ol v e ment in inflam mat or y r esp onse s [19-21, 25, 26]. 122 Init ial anal y se s confi rm ed tha t t h e pr es ence of Cr e r e co mb ina se al lele, th e 123 T o ma to r e p or ter a l l e l e, o r bo th did n o t a l t e r th e o vera l l com p os i tion o f m aj or c e l l 124 populat i ons in ei the r the G I trac t (Suppl em ental Fig ur e 3B ) o r the N AL T 125 (Supplem ent al F igur e 3C ). W e de t ect ed T o mat o flu or es cen ce onl y i n P gl y rp1 Cr e/wt 126 R o sa26t d To m / w t animal s, w ith st r on g e xpr es si on ac r o ss G I ep ith eli al s ubs ets (F igur e 127 3A). Go ble t c ells (Cd45 - Ep ca m + Gp2 + T nfaip2 - ) , i mm atu r e M cells (Cd 45 - Ep ca m + Gp2 -128 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint T nfaip2 + ), and m atu r e M cells (C d45 - Ep ca m + Gp2 + T nfaip2 + ) a l l ex hib i t e d v e ry h ig h 129 T om at o po si ti vi ty , indi ca ting b r o ad Pglyrp1 p r o mo ter a ctivi t y i n g u t e pi thel ial l ine ages 130 (Fig ur e 3A ). 131 In c ont r as t , T om at o e xpr ess i on in t he N AL T of P gl ryp1 Cr e/wt Ro sa 2 6 tdT o m/wt adult 132 m ic e was mo r e he tero ge n eo u s ( Fi gu re 3B ) . Ne u tro ph i l s ( Cd45 + Epc am - L y6g + ) sh ow ed 133 the h igh es t r epor t er e xpr e ssi on, w hile ep it heli al su bs ets d ispl a y ed v ari abl e T o mat o 134 le v el s. T uft cell s (Cd45 + Ep ca m + ) sh ow ed the s tr onges t epi thel ial e xpr ess ion ( ~70 %), 135 w her eas g oble t cell s (Cd45- Epc am +Gp2+T nfa ip2-) and M cell su bs ets , b oth i mm at ure 136 (Cd45- Epc am+ Gp2-T nfa ip2+) and m at ure (Cd45- Epc am+ Gp2+T nfa i p2+), di spla y ed 137 int er med iat e e xpr es si on ( ~50 %) . 138 T oge ther , th es e da ta r e v e al di st inct tis sue- spe cifi c p att erns of Pglyrp1 pr o mot er 139 ac ti vi ty: pr edo min antl y ep ith eli al in the gu t , and m or e im mune- enri ch e d in t he N AL T . 140 141 Pglyrp1 -Cre–Rosa26 DTA mice show no det ectable changes in epithelial or 142 immune composition 143 T o t es t w h eth er Pglyrp1 - ex p ress i n g popul at ions c ould b e d eplet ed b y 144 cons ti tut i v e diph the ri a t o xin e xpr es sion , w e c r o sse d Pglyrp1 -C r e mi ce wit h B6.1 29P2-145 Gt( R OS A)26S or tm1(D T A)Lky / J ( h erea ft e r R o sa 2 6 DT A ) mi ce , e xp ect ed t o d ri v e c ell-int rins ic 146 diphth er ia t o xin (D T A ) e xpr e ssi on in C r e-p os it i v e line age s [27]. W e ana l yzed the 147 impa ct of thi s c ons ti tut i v e abl at ion appr o a ch on mu co sal cell p opula t ions in th e gu t 148 and N AL T b y flo w cyt o met ry , us i ng a r ef ined ant ib od y pan el d es ig ned t o ident ify 149 epit heli al su bse ts , includ ing GP2 + a nd GP2 – popul at ions , and m aj or i m mune line age s 150 (Supplem ent al F igur e 4A , or ange boxes ). A na lysi s by fl ow cy tome t ry de m onst r at ed no 151 signifi c ant d iff er enc es in epi thel ial or i mmun e p opula ti ons in GI trac t o r NA L T a cros s 152 genot ype s ( Fig ure 4 A, B) . N ei th e r GP 2 – nor GP2 + ep ith eli al pop ulat ion s w er e r edu ced. 153 Thus , cons ti tut i v e D T A e xpr es si on did no t d eplet e Pglyrp1 -e xpr ess ing cell s in 154 muc os al t is sue s, sugge st ing li m it ed t o xin effi ca cy or c omp ens at o ry sur vi v al 155 me chan ism s. 156 157 Pglyrp1 -Cre–dri v en expr ession of GFP -D T A r esults in perinatal lethality and 158 mosaic expr ession in survi v ors 159 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint F ollo wing th e l ack of d et e ct able c ell lo ss in Pglyrp1 - Cre– R o sa26 DT A mi ce, w e 160 ne xt t est ed a se c ond D T A-e xp ress i n g mo us e l ine t ha t als o inc or por at es a Cr e-161 independ ent GFP r epo rt e r ups tream o f t he D T A c a ss et te at t he R o s a26 l oc us. Thi s 162 mod el, B6.129S6 ( Cg)-G t( R OS A)26 Sor tm1(D T A)Jpm b / J ( h erea fte r Ros a 26 GFP-DT A ) [28], 163 enabl es b ot h funct ion al abl at ion of Cr e- e xpr es sing cells and fluor es cen t lab eling of all 164 cells ca rry ing th e ta rg et ed allele , i ndependent of r e co m bina ti on. A nalys is o f cros s es 165 r e v eal ed ma rk edl y r edu ced su rv i v a l of P gl yrp1 Cr e/wt R o sa26 GFP-D T A/wt p ups at w e aning 166 (Supplem ent al Fig ur e 5 A ), w ith c lose r exam i n at io n re v e a l i n g s i g n i fi c ant pe rina tal 167 leth alit y a mong P gl y rp1 Cr e/wt R osa2 6 GFP-DT A/wt pups. M ost P gl y rp1 Cr e/wt R o sa26 GFP-D T A/wt 168 pups d ied wi th in t he f i rst 24-48 h o urs of life and de ce as ed pup s e xh ib it ed a bdo min al 169 dist en si on wi th fluid ac cu mula ti on sugg est i v e of int e st inal d y sfu ncti on. Ma rk ed 170 inflam mat i on and t is sue deg r ad at i on o bs er v ed in t he abd om inal r eg i on of d ec ea sed 171 pups pr e v ent ed the ir c olle ct ion for hist olog ic al ana lysi s. 172 Despit e r ep eat ed br eed ing att emp ts, onl y a s mall num be r of d ou ble -pos itiv e 173 anim als su rv i v ed t o w e aning. Th es e r ar e su rviv o rs were u se d to ex a min e th e e ff ec ts o f 174 cons ti tut i v e D T A e xp r es si on on m uc osal c ell p opulat i ons in th e g ut (F ig ur es 5A , B ) and 175 N AL T (F igur es 5 C, D) using th e sa me fl ow c yt o me tr y p anel emplo y e d in t he T o mat o 176 re p or ter e xper i ment s (Supple men t al F ig ure 3 A) . Be ca u se M c e l l s a re p re se n t at low 177 abundan ce , th e y w er e an al yzed sepa r at el y fr om ot her epi th elia l and im mun e 178 populat i ons in bo th t he gu t (Fig ur e 5B ) and N AL T (F igur e 5D) . S urpri sin gl y , the 179 a n a lysi s r ev e a le d no sign ifi cant d iff er en ce s in o vera l l ce l l p opula ti ons ( Figur e 5A ) o r M 180 cell sub se ts (F igur e 5 B) in the GI t r ac t , n or in co rr esp onding p opula ti o ns in the N AL T 181 (Fig ur e s 5C, D) , w hen c omp ar ing Pglyrp1 -Cr e–p os it i v e GFP-D T A m i c e wit h c ontr ol 182 litt e rm at e s t ha t on l y con ta ined the Cr e- inse rt ion . 183 T o unde rst and w h y s om e do ubl e-pos itiv e a ni ma l s su r vi ve d wh i le ot h ers d ied , 184 w e e x a mined G FP e xpr ess ion a s a surr og at e for D T A e xpr ess i on in GI t ract and N AL T 185 tis sue s of su rv i v ing m ic e. De spit e b eing dr i v en b y a C r e- independ ent prom o t e r at t he 186 R o sa26 l oc us, s urv i ving do ubl e-pos it i v e ani mal s sh ow ed m os ai c GFP e xpr ess ion , wi th 187 onl y 32 % of gu t c ells and 55 % of N AL T c ells e xpr es sing GF P , sugge st ing inc ompl et e 188 tr an sgene a ct i vit y in su r vivi n g m ic e (Supple men tal F igu r e 5 B) . 189 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint The se findings sugg est th at wid esp r ead D T A e xpr es si on in Pglyrp1 + li neage s i s 190 inc ompa ti ble w ith ne ona tal su rviv a l , w h e r e as m os ai c ex p r e s sio n i n surv i v ors li mi ts 191 det e ct able depl et ion. 192 193 Assessment of mucosal cell depletion using Rosa26 iDTR and diphtheria toxin 194 T o a v oid per ina tal l eth alit y and all o w t e mpo r al c ontr ol of a blat i on, w e used the 195 induc ible C57 BL/6-G t( R OS A)26S o r tm1(HBE GF)A wai /J str ain (h erea fte r re f e rre d t o a s 196 R o sa26 iD TR ), w h ic h e xpr e sse s th e d i phthe ri a t o xin r ec ep tor ( D T R) i n a C re - d epend ent 197 manne r [29]. In t his sy st em , Pglyrp1 -e xpr ess ing cells r em ain vi abl e un less sel e ctiv e l y 198 deplet ed b y adm inis tr at ion of e x ogen ous d iphth er ia t o xin (D T). T o det er mine an 199 appr op ri at e D T d os e, w e fi rst p erf o rmed a t i trat io n s tu dy u s i n g i n tra pe r i t o n ea l ( 1 00 , 200 200, 3 00, and 500 ng) and int r ana sal (200 , 300, 500, and 1 ,000 ng) deli v e ry r out es 201 (dat a no t sh own ), foll ow ing tr e atm ent r egi men s p revi ou s l y re po r t e d fo r th e 202 R o sa26 iD TR str a in [29-32]. A t d os es ab o v e 200 ng, ani mals e xhi bit ed s igns of t o xi ci ty 203 including pe ri anal blee ding, r e duc e d m ob ility , and a bdo min al sw ell ing, in s o me c ase s 204 as ea rl y a s 24 hou rs aft e r t he f irs t adm inis tr at ion . B ased on th ese o bs ervat i ons, w e 205 sele ct ed 2 00 ng as the h ig hes t d os e th at pr odu ced n o let hali ty and m inim al dis tr es s 206 for bo th intr ape rit one al and int r ana sal a dm inis tr at ion. 207 In th e gu t , int r ap erit one al D T in cr eas ed B c ells (Cd4 5 + Epc am - Ly 6 g - F4/80 -208 B220 + ) re gard l es s o f geno typ e and c aus ed mod es t , n on-sign ifi cant d ecre as es i n so me 209 epit heli al sub se ts ( Fig ures 6A , B ). M ce l l p opula ti ons r em ained un c hanged. In th e 210 N AL T , D T r edu ced B cells and ne utr ophil s in P gl yrp1 Cr e/wt Ro sa 2 6 iD TR/wt mice and 211 i n c r e as e d u n ch arac ter i z e d e pi t he l ia l c e l l s ( Cd45 - Ep ca m + Gp2 - T n fai p 2 - ), bu t ag ain M 212 cell fr eq uen ci es w er e un aff ect ed (Fi gur e s 6C , D ). 213 Intr anas al D T p r odu c ed s im ila rl y m odes t chang es in b ot h gut and N AL T , and did 214 not signific antl y alt er M c ell a bunda nce (Fi gur es 6 E –H ). 215 Thus , Pglyrp1 -C r e –dr i v en D T R e xp r es si on all ow s c ont r oll ed abl at ion of so me 216 populat i ons but fail s t o d eplet e M cells or o the r Pglyrp1 -e xpr e ssi ng linea ges a t 217 to l era t e d DT d os e s. 218 219

Discussion

220 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint W e g ene r at ed a Pglyrp1 -Cr e kno ck-i n mou se mod el d esign ed t o pr o v ide gene tic 221 ac ce ss t o Pglyrp1 -e xpr e ssing line ages , includ ing M c ells. T he knock- in s tr at eg y 222 pr es er v ed endog enou s pr om ot er r egula ti on and r esult ed in h eal th y , fertil e an im als, 223 indic at ing m ini mal dis rupt ion t o P gl yrp1 fun ct ion. 224 Our findings de m onst r at e tha t P glyrp1 p r o mo ter a ctiv it y is hi gh l y ti ss u e 225 spec ifi c. In th e gu t , Pglyrp1 - Cre m ar ks M c e l ls , g ob l et c e l l s, and oth er ep ith eli al 226 subs et s, w h ile in the N A L T i t m ar ks neutr ophil s and tuft c ells m or e pr om inentl y . Th is 227 unders c or e s the i mpo rtan ce of ti ss ue con text i n i n ter p r e t i n g Cre driv e r a ctiv it y a n d 228 highl ig hts t he c halleng e of a chie vin g M cell-sp ec if i c g ene ti c ta rg et ing acr os s mu co sal 229 s i tes . 230 F unct ion al s tudi es fur the r und ers co r ed th es e li mi ta ti ons. C ons tit ut i v e D T A 231 e xpr es si on cau sed p er inat al l eth alit y , sugg es ting es sent ial r oles for Pglyrp1 -e xpr essing 232 cells ea rl y in l ife, po ss ibl y r el at ed t o gut ba rr ier ma tur at ion du ring ne o natal feed ing. In 233 cont r ast, indu ci ble iD TR- med iat ed abla ti on r e sult ed in lim it ed d eple ti on at t ole r at ed 234 D T d os es, s ugge sting tha t inc omp let e upt ak e or r es tr ict ed t o xin a c ces s c ons trai n s 235 eff ect i v e line age a bla ti on. 236 Despit e th ese ch allenge s, Pglyrp1 -Cr e pr o v ide s a us eful t o ol f or pr ob ing 237 Pglyrp1 -e xpr es sing pop ulat i ons in vivo . I ts ac tivi ty i n e pi t he l ia l and im mune 238 co mpa rt ment s ena ble s st udi es of m uco sal h o me ost as is, innat e im mune signal ing, and 239 bar ri er func ti on. T he le thal it y ob s er v ed w ith G FP-D T A hi ghli gh ts th e physi o lo g ic a l 240 imp ort anc e of t hes e l ineag es dur ing the ne onat al pe ri od. 241 M ore b r o a dly , t h is w o r k i l l u stra t e s th at M ce l l - a ss oc ia te d gene e x pr es si on 242 p a t ter n s v a ry a cros s ti s su e s a n d o ver l a p wi t h o t he r e pi t he l ia l and i mmun e sub se ts. 243 Insi ght s fr om t his m od el w ill gu id e fut ur e eff ort s t o d e v elop ne xt-ge ner a ti on M cell-244 spec ifi c Cr e dr i v e rs wi th imp r o v ed t issu e spe cifi ci ty . 245 246 247

Material and methods

248 Animals 249 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint The P gl y rp1-Cr e m ou se w as g ene r at ed us ing th e E as i-C RISP R t e chni que [22], 250 as de tail ed b elo w , in c olla b orat ion w it h t he C hi l d r e n ´ s Me d ic a l Ce n te r Res ea r c h 251 Insti tut e G eno me Engin ee ring C ore a t UT S ou t hw e s t ern. 252 The R os a26 DT A str a in ( B6.129P 2-G t(RO SA )26S or tm1(D T A)Lky /J) [27], R osa 26 GFP-D T A 253 str ain (B6.129S6 ( Cg)-G t( R OS A)26 Sor tm1(D T A)Jpm b /J) [28], and R os a26 iD TR s t rai n 254 (C57B L/6-G t( R OS A)26S or tm1(HBEGF)Aw a i /J) [29] w er e o bt ain ed dir ec tl y fr om Th e 255 Ja ck son L a bora t o r y . T he T om at o r e p or ter st r a i n (B6. Cg- Gt(ROSA)26Sor tm14(CAG-256 tdTomato)Hze /J) [23] w a s gen erou s l y prov ided b y Deni se Mar c iano at UT Sou th w est ern. 257 All m ic e w er e main ta ined on a C57 Bl/6J gene ti c ba ck grou n d . 258 Geno typing of mi c e and em br y os w as p erf o rm ed a cc or d ing t o t he p r ot oc ols 259 pr o v ided for ea ch s t r ain b y Th e J a ck son L ab or at ory . Th e gen otyp ing str at eg y fo r th e 260 P gl yrp1- Cr e mo use i s d es cr ib ed in th is m anus cr ipt . Br iefl y , g eno mi c DNA w a s 261 e xtr act ed fr om t ail bi ops ies of n e w bo rn pups or e ar pun ch es of w ean ed m ic e u sing a 262 pr e vi ou sl y des cr ib ed p r ot oc ol [33]. 263 All e xper im ent al pr oc edu r es w ere appr o v ed b y t he Inst it ut ional Ani mal C are 264 and Use Co mm itt ee ( IA CUC) of UT South w e st ern . M i ce w er e h ous ed under sp ec ifi c 265 path ogen-fr ee c ondit ion s in a cc or d a nce wi th inst itu ti onal g uid eline s. 266 Gener ation of Pglyrp1 -Cre mice 267 Suit able pr ot o spa ce r adja cen t mo ti f (P A M) s it es w er e i dent ifi ed w it hi n e x on 3 268 of t he Pglyrp1 lo cus t o gu ide C RIS PR-as so ci at ed pr ot ein 9 (C as9 )-me diat e d d oubl e-269 str and br ea ks . Th e DN A r epai r t e m plat e c ons ist ed of a 2,0 15-ba se p ai r ssD N A d ono r 270 cont ain ing h o mol ogy a rm s flank in g th e ta rg et ed cut s it e , an I R ES, and t he c oding 271 seq uenc e of C r e r e co m bina se (F igu r e 1B ; Supple men tal F igu r e 1 A) . T h e I RES ele men t , 272 pr o v ided b y the Child r en´s Me dica l Cent er R e se ar ch Ins ti tut e G eno me Engine er ing 273 Co r e at U T S outh w est ern , ens ur ed independ ent t r anslat i on of Cr e reco mb i n as e from 274 the endog enou s Pglyrp1 tr ans cr ipt . The Cre s equ enc e (1 ,026 bp, e x cluding th e st ar t 275 and st op cod ons ) w as ob tai ned fr o m th e A ddgen e Seq u ence Anal yzer 276 (ht tps: //w ww . addgen e. o rg/b r ow s e /se quen ce /199783/ ), and th e ssD N A d ono r 277 cons tru c t w as s ynth es ized vi a G ene wiz s ingle- st r anded D N A s ynth esi s ser vi ce . 278 T o fac ili tat e g enot yping, Ec o RI and Nh eI r e str ic ti on enzym e r ec ogni ti on s i tes 279 w er e ins ert ed a t th e 5@iLH and 3@iLH e nds of th e c ass ett e. The endog eno us Pglyrp1 s to p 280 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint cod on w as p r es er v ed, w h ile the Cr e se qu enc e w as flank ed b y ind epe ndent st ar t and 281 st op c odons t o ens ur e ind ependen t e xpr es si on of b oth pr ot e ins. Fin all y , w e int r odu ce d 282 a sil ent p oint mut at ion wi thin the P AM s eq uenc e ( hi ghli ght ed in r ed , Supplem ental 283 Figur e 1B ) t o pr e v ent r ep eat ed C a s9 r ec ogni ti on and r e- cut ting. Th e r eq ui r ed g uid e 284 RN A w a s or d er e d fr om ID T . 285 Z ygo te i n jec t io n s w e r e pe r for me d by t he C hi l d r e n ’ s Me d ic a l C e n ter Res ea r c h 286 Insti tut e Gen om e Eng ine ering C ore a t U T S outh w es t ern u sing s tand ar d Eas i-C RISP R 287 pr ot oc ols. 288 Whole-mount immunofluor escence on newborn pups 289 The eu than asi a and fix a ti on of w hole ne wb orn p ups w er e p erf o rmed in 290 ac co r dan ce wi th th e g uid eline s of I A CUC of UT Sou th w est ern. Br iefl y , 1-da y- old pup s 291 w er e eu than ized, d ec api tat ed, and skinned t o fac ili tat e th e f ix at i on. Th e ent ir e b odi es 292 and h eads w er e fix ed wit h 4 % p arafo r ma l d ehyde ( P F A, T he rm o S ci e nt if i c ), e mb e dded 293 sagi tt all y in p ar affin, se ct ioned a t 5 μm, and m ount ed on glas s sl ide s. 294 F or im muno st aining , sl ides w ere depa r affin ized u sing xy l ene and eth ano l 295 w as hes , foll ow ed b y he at-m edi at ed antig en r e tr ie v al in 10m M s odiu m c itr at e (pH 6 .0) . 296 Tis sue se ct ions w er e th en p er me ab ilized and bl o ck ed fo r 1 hou r a t room t e m pe r a t ure 297 in 0.4 % T r it on X-100 and 5 % bovin e s er u m a lb u mi n (B SA ) i n PBS (bl ock ing s olut ion 298 wit h T r it on ). Aft e r w a shing wi th PBS, slid es w ere i nc u ba te d o vern i g h t at roo m 299 te m p erat ure wi t h a 1: 1 0 0 d i l ut io n of r a bb it anti- RFP (R o ckland #D600-401-379S) and 300 r at ant i-Gp2 ( MBL #D278-3 ), in blo cking solu ti on w it h T r it on. Th e foll ow ing d a y , 301 slide s w er e w ash ed wi th PBS and incu bat ed fo r 1 h ou r a t r o om t e m per a tur e wi th a 302 1:400 dilu ti on of go at anti -rab bi t IgG-Ale x a Flu or 48 8 (In vi tr ogen #A11008) and 303 d o n key a n ti - r a t I g G A l exa F l uo r 594 ( I n v it r ogen #A21209 ), in blo ckin g solu ti on wi th 304 T r it on. Aft e r a final se ri es of PBS w as hes , sl ide s w er e in cub at ed wi t h D API , w as hed 305 ag ain, mount ed in Pr ol ong Gold a ntifade r e agent, and i mag ed us ing an Axio sc an.Z1 306 slide s canne r ( Ze iss ). 307 Flow cytometry 308 Single- cell s uspen si ons fr om g ut and N AL T ti ssu es w er e pr epa r ed using a 309 m o di fi e d v e rs io n o f a previ ou s l y d es c ri be d pro t o co l [34]. Bri efl y , a se ct ion of t he ileu m 310 and the N AL T w er e c olle ct ed s epa r at el y , min ced wi th s cis so rs , and di gest ed in RP MI 311 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint 1640 m ediu m (G ib co ) con tain ing 1 0mM H EPES , 5 % h ea t-ina ct i v at ed FBS, 30 μg/ml 312 Dnase I ( R oc he ), and 1mg /ml Coll agena se II (W or thingt on) at 37 ºC for 45 m inut es . 313 The r e sult ing c ell su spens ion w a s pass ed th r o ugh a 70 μ m n y l on c ell str ain er (F alc on 314 #352350), cen trifu ged, and w ash e d in A CK (A m moni um- Chlo rid e-P ot ass ium ) l y si s 315 buff er ( Gi bc o #A10492-01 ). Cell s w er e th en r es uspend ed in 5 % BS A in PBS 316 (F A CSbuff e r) . 317 F or i mm unos ta ining, cells w e r e in c ubat ed w ith the anti b od y p anels sp ec ified in 318 ea ch s ec ti on of th e R e sults , f oll o w ed b y w ash ing and in cub at ion wit h se c ondar y 319 anti bod ie s in F A CS buff er , if n eed ed . Aft er st aining , cells w ere w a s he d and fix ed in 4 % 320 PF A in PBS for 3 h ou rs ( or 1 % PF A in PBS o v e rnig ht ) follo w ed b y ana l y sis on an LS RII 321 flow cyt o met er (BD Bi os ci enc es) an d anal yzed u sing Fl owJ o sof tw ar e . 322 The foll ow ing ant ib od ies w er e used: r a t Ep ca m ( Cd326 )-B V421 (1:200 , 323 Bio Leg end #118225) , r at Cd45- AP C-C y7 (1 :200, Bi oleg end #103115 ), r a t L y6g-P E-324 eFluo r610 (1 :200, In vit r o gen #6 1-9668-82), r at L y6G-A lexa F lu or 4 8 8 ( 1: 200, 325 Bio Leg end #127625 ), r a t F4 /80-P e rCP-C y5.5 (1 :200, Bi oleg end #1231 28), r a t F4 /80-326 PE (1 :200, Bi oleg end #123110), rat B220-PE-C y7 ( 1:200 , Bi oleg end #103221), r a bb it 327 T nfaip2-C F647 (1:100 , B io rb yt # or b101923- CF647 ), r a t Cd3 -Per CP - Cy 5 . 5 ( 1: 200, 328 Bio Leg end #155615) , rab bi t Gp2-FI T C (1:100 , B i orby t # or b 37776) , r ab bit Gp2 (1:10 0, 329 B i orby t # or b623866 ), g oa t ant i-r a bb it IgG-A lexa F lu or 6 4 7 ( 1: 20 0 , I n v it r ogen 330 #A21245) . 331 Diphtheria toxin inoculations 332 R o sa26 iD TR mic e, wi th o r w ith o ut P g l yrp 1-Cr e inse rt ion, w ere i n j ec te d 333 intr ape rit oneal l y fo r t hree co n se c ut i ve day s w ith 100 μl of ei the r PBS or 200ng of D T 334 (Sig ma ) pe r inje ct ion using a 1 ml tu ber cul in syr inge (BD #309626) . 335 F or int r ana sal in oc ulat ion s, th e sa me r egi men w as foll ow ed , wi th ea ch m ous e 336 r e ce i v ing e it her 10 μl of PBS or 200 ng of D T (S igm a) vi a a 2-20 μl pipett e. 337 All m ic e w er e 8-11 w e ek s of ag e, a nd all an im als w er e se x- and age- mat ched . 338 Ea ch e xper im ent w a s r epe at ed a t le ast tw ic e. 339 Statistical anal ysis 340 Stat is ti cal anal y ses w ere perfo rm ed us ing G r aph P ad Pri sm 341 (R RID:S CR _002798 ). F or fl ow cyt o met ry st udi es, tw o- w a y AN O V A w it h c o rrec ti o n fo r 342 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint mult iple co mpa ri sons w as used w h en t hree ex p er im e nt a l gro u ps w e r e p re s ent. W hen 343 onl y tw o gr oups w e r e co mpa r ed , mult iple Mann-W hi tne y t est s w i th H olm-Sid ak 344 co rr ec ti on w e r e p erfo rm ed. Su rv i v al s tud ies w er e an al yze d us ing Kaplan-M ei er 345 a n a lysi s. P - v a l u es a r e indi c at ed i n th e figu r es ; o the rw is e, c omp ar i sons w er e not 346 signifi c ant . Sta ti st ic al signif ic anc e w as d efin ed as f ollow s: *p<0 . 05, **p<0 .005, 347 ** *p<0.0005 , ** **p<0 .0001. 348 349

Acknowledgements

350 The aut ho rs thank th e c or e fa cil it i es a t UT Sou th w est ern Med ic al C e nt er fo r 351 the ir v alua ble cont ri but i ons t o th i s w o rk, includ ing th e Child r en´s Med ic al Cent e r 352 R e se ar ch Ins ti tut e Gen om e Eng inee ring c or e, p ar ti cula rl y t o the c or e d irec tor H ao Z hu , 353 and Lin L i, Y u Zhang , and T r ipt i Sh arm a; th e H ist opat hol ogy C ore, p art ic u l ar ly to t he 354 co r e d ir ect or Br et E v e rs, and J oh n Shelt on; th e Wh ole Br ain Mi cr os cop y F ac ilit y 355 (R RID:S CR _017949 ), pa rt ic ula rl y t o D enis e R a mi r ez; the Fl o w C yt o met ry F a cil ity , 356 part ic ula rl y t o Da vid F a rrar ; a n d th e Mo ody F o undat ion Fl o w C yt om etr y F ac ilit y for 357 pr o v iding a cc ess t o G r aph P ad Pri sm softw ar e. 358 359 Competing inter ests 360 All au th ors de cla r e tha t the y h a v e n o co mpe ting int er es ts. 361 362 Funding 363 Thi s w ork w as suppo rt ed b y t he Na ti onal In st itut es of H eal th U01 AI12593 9 364 and R01 A I184584 t o M.U .S. 365 366 Author contributions 367 Con cept ualiz ati on, S.A .A ., M.U .S. ; F or mal anal y si s, S.A .A. , M.U .S. ; In v e stig a ti on, 368 S.A. A.; F unding a cq uis it i on, M.U .S. ; Pr oj e ct ad mini s trat io n , S. A .A . , M . U .S . ; S u pe rv i sio n , 369 M.U .S.; W r it ing – ori ginal dr aft , revie w and ed it ing, S. A. A., M .U .S. 370 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint

References

371 1. R o e, K ., The epithelial c ell types and their multi-phased defenses against fungi 372 and other pathogens. Clin Chi m A ct a , 2024. 563: p. 119889. 373 2. K o ba y ash i, N ., et al. , The Roles of Peyer's Patches and Microfold C ells in the Gut 374 Immune S ystem: R elevance to Autoimmune Diseases. F r on t Im munol , 2 019. 10 : 375 p. 2345. 376 3 . M ab bo tt , N . A ., e t a l . , Microfold (M) cells: important immunosurveillanc e posts in 377 the intestinal epithelium. M uc os al I mmun ol, 20 13. 6(4 ): p. 66 6-77. 378 4. Co rr , S. C. , C .C . G ahan, and C. Hill, M-cells: origin, morphology and role in mucosal 379 immunity and microbial pathogenesis. F EMS Im mun ol M ed Mi cr ob i ol, 2008 . 380 52 (1) : p. 2-12. 381 5. T e it el bau m, R ., et al ., The M cell as a portal of entry to t he lung for the bacterial 382 pathogen Mycobacterium tuberculosis. Im muni ty , 1999. 10 (6 ): p . 641-50 . 383 6. Na ir , V .R. , et al., Microfold C ells Actively T ranslocate Mycobacterium tuberculosis 384 to Initiate Infection. Cell R ep, 2016 . 16 (5) : p. 1253-1258. 385 7. Khan, H.S ., et al ., Identification of sc avenger receptor B1 as the airway microfold 386 cell receptor for Mycobacterium tuberculosis. E li fe , 2 02 0 . 9. 387 8. Dillon, A. and D .D . Lo , M C ells: Intelligent Engineering of Mucosal Immune 388 Surveillance. F r ont Im munol , 2019 . 10: p. 1 499. 389 9. Knoop, K.A ., et al. , RANKL is ne cessar y and sufficient to initiate development of 390 antigen-sampling M c ells in the intestinal epi thelium. J Im mun ol, 2009. 183(9 ): 391 p. 5738-47. 392 10. W ang, J., et al ., Converg ent and divergent development among M cell lineages in 393 mouse mucosal epithelium. J I mmun ol, 201 1. 187(10 ): p. 5 277-85. 394 11. Kana y a , T ., e t al., The Ets transcription factor Spi-B is essential for the 395 differentiation of intestinal microfold cells. Na t Im munol , 2012 . 13 ( 8) : p . 729-36. 396 1 2 . K i m ura, S . , et a l ., Sox8 is essential for M c ell maturation to a cceler ate IgA 397 response at the early stage after weaning in mice. J Exp Me d, 2019 . 216 (4 ): p . 398 831-846. 399 13. Mad is on, B.B ., e t al ., Cis elements of the villin gene control expr ession in r estricted 400 domains of the vertical (crypt) and horizontal (duodenum, cecum) ax es of the 401 intestine. J B iol Ch em , 2002 . 277(36 ): p . 33275-83 . 402 14. Ri os, D ., et al., Antigen sampling b y intestinal M c ells is the principal pathway 403 initiating mucosal IgA production to commensal enteric bacteria. Muc os al 404 Imm unol, 2016. 9 (4) : p. 907-16. 405 15. K ur a shi ma , Y ., et al., Pancreatic glycoprotein 2 is a first line of defense for 406 mucosal protection in intestinal inflammation. N at C o mmun, 20 21. 12 (1 ): p. 407 1067. 408 16. Geo rg e, J. J. , e t al., PRC2 R egulated Atoh8 Is a Regul ator of Intestinal Micr ofold C ell 409 (M C ell) Differentiation. Int J Mol Sc i, 2021. 22 (17 ). 410 17. Lo, D ., e t al. , P eptidoglycan recognition protein expression in mouse Peyer's Patc h 411 follicle associated epithelium suggests functional specialization. C ell I mmun ol, 412 2003. 224(1 ): p. 8-16 . 413 18. Hab er , A .L. , e t al., A single-c ell survey of the small intestinal epithelium. N a t ure, 414 2017. 551(7680 ): p. 3 33-339. 415 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint 19. Dziarsk i, R. and D . Gup ta, R eview: Mammalian peptidoglycan rec ognition 416 proteins (PGRPs) in innate immunity . Innat e Im mun, 2010. 16 (3 ): p . 168 -74. 417 20. Liu, C., et al., P eptidoglycan recognition proteins: a n ovel family of four hu man 418 innate immunity pattern recognition molecules. J Bi ol Ch em , 200 1. 276 (37 ): p. 419 34686-94. 420 21. P a rk, S.Y ., e t al., Peptidoglycan recognition protein 1 enhanc es experimental 421 asthma b y promoting Th2 and Th17 and limiting regulatory T cell and 422 plasmacytoid dendritic c ell r esponses. J Im mun ol, 2013 . 190(7 ): p. 348 0 -92. 423 2 2 . M i ura, H ., e t a l., Easi-CRISPR for creating knock -in and conditional knockout 424 mouse models using long ssDNA donors. N at Pr ot o c, 2018. 13 (1 ): p. 195- 215. 425 23. Mad isen , L ., et al ., A robust and high-throughput Cre reporting and 426 characterization system for the whole mouse brain. Na t N e uros c i, 201 0. 13 (1) : p. 427 133-40. 428 24. Al v ar ez-A rgu edas , S. , et al., Single c ell transcriptional analysis of human 429 adenoids identifies molecular features of airway microfold c ells. Muc os al 430 Imm unol, 2025. 431 25. Dukhanina , E.A ., et al. , A new role for PGRP - S (T ag7) in immune defense: 432 lymphocyte migration is induc ed b y a chemoattractant complex of T ag7 with 433 Mts1. C ell C y cl e, 2015. 14 (22 ): p. 36 35-43. 434 26. Kang, D ., e t al ., A peptidoglycan r ecognition protein in innate immunity c onserved 435 from insects to humans. Proc N at l A ca d S ci U S A , 1998. 95 (17 ): p. 1 0078 -82. 436 27. V oehr inger , D . , H. E. Li ang, and R. M. Lo ck sle y , Homeostasis and effector function 437 of lymphopenia-induc ed "memory-like" T c ells in constitutively T c ell-depleted 438 mice. J I m munol, 2008. 180(7) : p. 4 742-53. 439 2 8 . I v a n o va, A ., e t a l . , In vivo genetic ablation by Cre-mediated expr ession of 440 diphtheria toxin fragment A. G enes is , 2005. 43 (3 ): p. 12 9-35. 441 29. Buch , T ., et al ., A Cre-inducible diphtheria toxin rec eptor mediates c ell lineage 442 ablation after toxin administration. Na t M et hod s, 20 05. 2(6 ): p. 4 19-26. 443 30. Brut tg er , J ., et al ., Genetic C ell Ablation Reveals Clusters of Local Self-R enewing 444 Microglia in the Mammalian Central Nervous S ystem. I mm unity , 2015 . 43 (1 ): p . 445 92-106. 446 31. R od rig uez-Ba ena, F .J. , et al., Micr oglial r eprogramming enhanc es antitumor 447 immunit y and immunotherapy response in melanoma brain metastases. Can cer 448 Cell, 2025. 449 32. Gri ts ch, S. , e t al. , Oligodendrocyte ablation triggers central pain independently of 450 innate or adaptive immune r esponses in mic e. N at C om mun, 2 014. 5: p. 5 472. 451 33. T ru et t , G. E. , et al. , Preparation of PCR -quality mouse genomic DNA with hot 452 sodium h ydroxide and tris (HotSHO T). Bi ot e chni que s, 2000. 29 (1 ): p . 52 , 54. 453 34. W olf, A. J., et al. , Mycobacterium tuberculosis infects dendritic c ells with high 454 frequency and impairs their function in vivo. J Im mun ol, 2007. 179(4) : p. 2509-455 19. 456 457 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint Figur e legends 458 459 Figur e 1. Generation of a Pglyrp1 -Cre mouse model and founder screening. (A ) 460 Geno mi c se quen ce of m ou se c hromo so me 7 s ho wing th e Pglyrp1 g ene, as vi sual ized in 461 the U CSC Gen om e br ow ser . (B ) Sc h ema ti c r epr es enta ti on of t he 2 ,015 bp ssD N A d ono r 462 cons tru c t , illus trat i n g a l l e le m ents includ ed fo r th e t a rget ed kn ock- in. ( C) Pr im er 463 loc at ions u sed t o ident ify th e Cr e r ec om bin ase inse rt ion a t the 5@iLH and 3@iLH ends of t he 464 mod ified gen om ic s equ enc e. IR ES = Int ernal r ib os om e en tr y s it e . 465 466 Figur e 2. R eporter expr ession in newborn Pglyrp1 -Cr e mice r ev eals tissue-467 specific patterns. ( A) C onfoc al i m ages of r epr es ent ativ e Pglyr p 1 wt/wt R osa26 tdT om/w t 468 (t op ), and P gl yrp1 Cr e/wt Ro sa 2 6 tdT om /wt (b ott om ) on e-da y-old p ups fr o m th e G I t is sue 469 (A ), and N AL T (B ) s ec ti ons st ain ed wi th anti- r ed fluo r es c ent p r ot ein ( RFP ), and an ti-470 GP2 anti bo die s. T he w hit e b o x h ig hligh ts th e ar ea s h own at h igh er magnific at ion in 471 the r igh t p anels . Clo sed a rr ow h ead point s t o T o mat o + GP2 - cells , open arr ow h ead t o a 472 To m a t o - GP 2 + c ells, and ast e ri sk t o T om at o + GP2 + cell s. Sc ale b ar s i ncluded in t he 473 pict ur es. 474 475 Figur e 3. Quantitati v e anal y sis of Pgl yrp1-Cr e dri v en T omato expr ession in adult 476 mice highlights tissue-specific patterns. F lo w c y t o me tr y a n alysi s o f P g lyr p 1 Cr e/w t 477 (bla ck s qua r es ), R o sa26 tdT om/w t ( gr a y t ri angle s), and P g l yrp1 Cr e/wt Rosa 2 6 tdT om/wt (r ed 478 cir cle s) gut ( A) and N AL T ( B) t issu es in ad ult mi ce . Ma rk ers us ed t o define ea ch c ell 479 populat i on are s pe ci fie d i n t h e x - a xis. Ind i vid ual da ta ar e plott ed wi t h m eans ± SD 480 anal yz ed wit h tw o-w a y ANOV A wi t h Ge i ss e r-Gr eenh ous e c o rrec ti o n ( no sphe ri ci ty 481 assu med ). *p<0.05 , **p<0 .005, * **p<0. 0005, * * **p<0. 0001. Whe r e n ot s ho wn, 482 co mpa ris ons w er e no t s ignifi can t. N = 7 ( Pglyr p 1 Cr e/wt ) and 10 ( R o sa26 tdT om/wt , 483 P gl yrp1 Cr e/wt R o sa26 tdT om/wt ). Ma r k ers used t o ident ify ea ch c ell populat i on ar e 484 desc ri bed in Suppl em ental T abl e 1 A . 485 486 Figur e 4. P gl yrp1-Cr e–R osa26 DTA mice show no detectable changes in epithelial 487 or immune cell composition. P e r cent age of t o tal cells in gut (A ), a nd N AL T (B ) in 488 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint R o sa26 D T A/DT A (black squ ar es ), P gl yrp1 Cr e/wt R o sa26 DT A / w t ( g ray t ri angl es ), or 489 P gl yrp1 Cr e/wt R osa 26 D T A/DT A mic e (bl ack c ir cles ). Ind i v idual da ta are p l o tte d wi th m ea n s 490 ± SD anal yzed wi th t w o- w a y A NO V A w it h Ge iss er- Gr e enh ous e co rr ec ti on (no 491 spher i cit y as sum ed) . Wh ere n ot sh ow n , c om p ar i sons w er e no t sig nific ant . N = 9 492 (R os a26 DT A / D T A ), 11 (P gl y rp1 Cr e/wt R o sa26 DT A / w t ), and 7 (P gl yrp1 Cr e/wt R o sa26 DT A / DT A ). 493 Ma rk ers us ed t o d efine e ach c ell p o pulati on thr ou gho ut all the gr aphs ar e sp ec ified in 494 the x-axis . Ma rk ers us ed t o id entify e ac h cell popul ati on ar e des cr ib ed in 495 Supplemen tal T a ble 1B. 496 497 Figur e 5. P gl yrp1-Cr e–dri v en expres sion of GFP -D T A r esults in perinatal lethality 498 and mosaic expr ession in survi v ors. (A ) Fl o w cyt om et ry anal y sis of cell p opula ti on 499 le v el s, and (B ) M c ell popul at ions i n gut t iss ue of P gl yrp1 Cr e/wt Ro sa 2 6 wt/wt ( gr a y b ar s) , 500 and P g l yrp1 Cr e/wt R o sa26 GFP-D T A/wt ( gr een b ar s) m i ce. (C ) Flo w cyt o m etr y anal y si s of 501 cell p opula ti on le v els , and (D) d et ailed le v els of M c ell pop ulat ion s of sa me m ic e in 502 N AL T . Ind i v idual da ta ar e plott ed wit h me ans ± SD anal yzed w ith mult iple M ann-503 Whi tne y t e st wi th H olm-Sid ak c o rrec t ion. ns = n ot s ignifi cant. N = 9 504 (P gl yrp1 Cr e/wt Ro sa 2 6 wt/wt ) , 9 ( P g lyrp 1 Cr e/ wt Ro sa 2 6 GFP-D T A/ wt ). M ar k er s u sed t o ident ify 505 ea ch cell p opula ti on are d es cr i bed i n Supplem ental T able 1A . 506 507 Figur e 6. Assessment of mucosal cell depletion using Rosa26 iDTR and Pgl yrp1-Cr e 508 under intr aperitoneal and intranasal D T tr eatment. (A ) Fl o w c yt o m etr y anal y sis of 509 cell p opula ti on le v el s, and ( B) M cell popul at ions in g ut tis sue of 510 P gl yrp1 wt/wt R o sa26 iD TR/wt (squar es ) and P g l yrp1 Cr e/wt R o sa26 iD TR/wt (trian gles ) mi ce 511 aft er in tr aper it oneal in oc ulat ion o f ei th er PBS o r 2 00 ng D T . ( C) F low c yt om etr y 512 a n a lysi s o f ce l l popula ti on le v els, a nd (D) M cell p opulat i ons of s am e mi ce in N A L T . 513 Indi v idu al da ta ar e plo tt ed wi th me ans ± SD anal yzed w it h tw o- w a y A NO V A and Sid ak 514 co rr ec ti on for mul tiple c omp ari s ons. Wh er e not sh own , c omp ar i sons w er e no t 515 signifi c ant . N = 6 (PBS ), 4 (200 ng D T). (E ) Fl ow c yt o me try anal y si s of cell p opulat i on 516 le v el s, and (F) M cell p opula ti ons i n gut ti ssu e of P gl y rp1 wt/wt R osa2 6 iD T R/wt (squa r es ) 517 and P gl yrp1 Cr e/wt Ro sa 2 6 iD TR/wt (tria ngles ) mi ce aft e r in tr anas al ino cul ati on of e it he r 518 PBS or 200 ng D T . (G ) Fl ow c yt o met ry an a lysi s o f ce l l p opula ti ons, and (H ) M c ell 519 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint populat i ons of s am e mi c e in N AL T . Ind i vidu al d at a ar e plo tt ed w it h me ans ± SD 520 anal yz ed wi th tw o-w a y AN O V A and Sid ak c orr ec ti on for m ultipl e c omp ari son s. Wh er e 521 not sh own, c omp ar is ons w er e n ot sign ific ant . N = 6 (P BS), 3 (200 n g D T) . Ma rk e rs 522 used t o iden tify e ach c ell pop ula tion a re d es cr ib e d i n Suppl em ental T a ble 1 A. 523 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint Figure 1 B C A Pglyrp1 (Exon 3) CreIRES EcoRI NheI Pglyrp1 (Exon 3) CreIRES EcoRI NheI 5´ Fw 3´ Fw 5´ Rv 3´ Rv Pglyrp1/ NM_009402.2 Pglyrp1 Scale chr7: .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint A B Pglyrp1Cre/wt Tomatofl/wt Pglyrp1wt/wt Tomatofl/wt Merge Merge Tomato GP2 50 µm 200 µm * * * * * * * * * * * * * * * 200 µm Merge Tomato GP2 50 µm Merge Pglyrp1Cre/wt Tomatofl/wt Pglyrp1wt/wt Tomatofl/wt 200 µm Merge TomatoMerge GP2 200 µm Merge Merge 50 µm Tomato GP2 50 µm Figure 2 .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint Figure 3 A B .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint Figure 4 A B .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint Figure 5 A B C D .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint Figure 6 BA DC FE HG .CC-BY-NC-ND 4.0 International licenseavailable under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made The copyright holder for this preprintthis version posted December 24, 2025. ; https://doi.org/10.64898/2025.12.22.696025doi: bioRxiv preprint

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-27T02:00:06.600101+00:00
License: CC-BY-NC-ND-4.0